日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A proof-of-mechanism trial in asthma with lunsekimig, a bispecific NANOBODY molecule

一项针对哮喘的机制验证试验,研究了双特异性纳米抗体分子lunsekimig的作用机制。

Deiteren, Annemie; Krupka, Emmanuel; Bontinck, Lieselot; Imberdis, Karine; Conickx, Griet; Bas, Selcuk; Patel, Naimish; Staudinger, Heribert W; Suratt, Benjamin T

Efficacy and Safety of Dupilumab in Children With Peanut Allergy: A Multicenter, Open-Label, Phase II Study

Dupilumab治疗花生过敏儿童的疗效和安全性:一项多中心、开放标签的II期研究

Sindher, Sayantani B; Nadeau, Kari C; Chinthrajah, R Sharon; Leflein, Jeffrey G; Bégin, Philippe; Ohayon, Jason A; Ponda, Punita; Wambre, Erik; Liu, Jinzhong; Khokhar, Faisal A; Akinlade, Bolanle; Maloney, Jennifer; Orengo, Jamie M; Hamilton, Jennifer D; Kamal, Mohamed A; Hooper, Andrea T; Patel, Naimish; Patel, Kiran; Laws, Elizabeth; Mannent, Leda P; Radin, Allen R

Immunomodulatory and clinical effects of receptor-interacting protein kinase 1 (RIPK1) inhibitor eclitasertib (SAR443122) in patients with severe COVID-19: a phase 1b, randomized, double-blinded, placebo-controlled study

RIPK1抑制剂eclitasertib (SAR443122)对重症COVID-19患者的免疫调节和临床疗效:一项1b期随机、双盲、安慰剂对照研究

Clot, Pierre-Francois; Farenc, Christine; Suratt, Benjamin T; Krahnke, Tillmann; Tardat, Agnes; Florian, Peter; Pomponio, Robert; Patel, Naimish; Wiekowski, Maria; Lin, Yong; Terrier, Benjamin; Staudinger, Heribert

Dupilumab in patients with prurigo nodularis: two randomized, double-blind, placebo-controlled phase 3 trials

Dupilumab治疗结节性痒疹患者:两项随机、双盲、安慰剂对照的3期试验

Yosipovitch, Gil; Mollanazar, Nicholas; Ständer, Sonja; Kwatra, Shawn G; Kim, Brian S; Laws, Elizabeth; Mannent, Leda P; Amin, Nikhil; Akinlade, Bolanle; Staudinger, Heribert W; Patel, Naimish; Yancopoulos, George D; Weinreich, David M; Wang, Sheldon; Shi, Genming; Bansal, Ashish; O'Malley, John T

Clinical Efficacy among Patients with Chronic Rhinosinusitis with Nasal Polyps and Clinical Features of Obstructive Lung Disease: Post Hoc Analysis of the Phase III SINUS-24 and SINUS-52 Studies

慢性鼻窦炎伴鼻息肉及阻塞性肺疾病临床特征患者的临床疗效:SINUS-24 和 SINUS-52 III 期研究的事后分析

Maspero, Jorge F; Bachert, Claus; Martinez, Fernando J; Hanania, Nicola A; Ortiz, Benjamin; Patel, Naimish; Mannent, Leda P; Praestgaard, Amy; Pandit-Abid, Nami; Siddiqui, Shahid; Hardin, Megan

Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial

Sarilumab治疗重症或危重症COVID-19住院患者:一项随机、双盲、安慰剂对照的3期试验

Lescure, François-Xavier; Honda, Hitoshi; Fowler, Robert A; Lazar, Jennifer Sloane; Shi, Genming; Wung, Peter; Patel, Naimish; Hagino, Owen

Conjunctivitis in Dupilumab Clinical Trials for Adolescents with Atopic Dermatitis or Asthma

杜普利尤单抗治疗青少年特应性皮炎或哮喘临床试验中的结膜炎

Bansal, Ashish; Simpson, Eric L; Paller, Amy S; Siegfried, Elaine C; Blauvelt, Andrew; de Bruin-Weller, Marjolein; Corren, Jonathan; Sher, Lawrence; Guttman-Yassky, Emma; Chen, Zhen; Daizadeh, Nadia; Kamal, Mohamed A; Shumel, Brad; Mina-Osorio, Paola; Mannent, Leda; Patel, Naimish; Graham, Neil M H; Khokhar, Faisal A; Ardeleanu, Marius

Dupilumab suppresses type 2 inflammatory biomarkers across multiple atopic, allergic diseases.

Dupilumab 可抑制多种特应性过敏性疾病中的 2 型炎症生物标志物

Hamilton Jennifer D, Harel Sivan, Swanson Brian N, Brian William, Chen Zhen, Rice Megan S, Amin Nikhil, Ardeleanu Marius, Radin Allen, Shumel Brad, Ruddy Marcella, Patel Naimish, Pirozzi Gianluca, Mannent Leda, Graham Neil M H

Dupilumab Provides Favorable Safety and Sustained Efficacy for up to 3 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic Dermatitis

在一项针对中重度特应性皮炎成年患者的开放标签研究中,度普利尤单抗显示出良好的安全性和长达3年的持续疗效。

Beck, Lisa A; Thaçi, Diamant; Deleuran, Mette; Blauvelt, Andrew; Bissonnette, Robert; de Bruin-Weller, Marjolein; Hide, Michihiro; Sher, Lawrence; Hussain, Iftikhar; Chen, Zhen; Khokhar, Faisal A; Beazley, Bethany; Ruddy, Marcella; Patel, Naimish; Graham, Neil M H; Ardeleanu, Marius; Shumel, Brad

Dupilumab Efficacy in Patients Stratified by Baseline Treatment Intensity and Lung Function

根据基线治疗强度和肺功能分层评估度普利尤单抗的疗效

Pavord, Ian D; Siddiqui, Salman; Papi, Alberto; Corren, Jonathan; Sher, Lawrence D; Bardin, Philip; Langton, David; Park, Hae-Sim; Rice, Megan S; Deniz, Yamo; Rowe, Paul; Staudinger, Heribert W; Patel, Naimish; Ruddy, Marcella; Graham, Neil M H; Teper, Ariel